Stelo Real-time Continuous Glucose Monitor Use Postpartum for Lifelong Optimal Wellness

Part of paid clinical trials in Santa Barbara, California.

Sponsor
Oregon Health and Science University
Study ID
NCT07356986
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Gestational Diabetes
  • Postpartum

Eligibility Criteria

Sex
FEMALE
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Dexcom Stelo real-time Continuous Glucose Monitor — DEVICE
    The Stelo Glucose Biosensor is an over-the-counter integrated Continuous Glucose Monitor (iCGM) intended to continuously measure, record, analyze, and display glucose values in people 18 years and older not on insulin. Participants will use Stelo for the 6 weeks following delivery and for 15 days at 3 months, 6 months, 9 months, and 1 year postpartum.

Study Details

The purpose of this prospective observational study is to gather exploratory and practical use data of the Dexcom Stelo Glucose Biosensing System (Stelo), an over-the-counter (OTC) real-time Continuous Glucose Monitoring (CGM) system among patients with Gestational Diabetes Mellitus (GDM) in their most recent pregnancy.

Key Dates

Start date
Jan 31, 2026
Status verified
Jan 2026
Primary completion
Dec 31, 2027
Completion
Dec 31, 2027

Study Design

Enrollment
50 participants (estimated)

Arms

  • Arm: Postpartum Stelo Users
    Postpartum individuals with their most recent pregnancy complicated by Gestational Diabetes Mellitus (GDM)

Primary Outcome Measure

Mean Glucose [ Time Frame: Measured from birth to 6 weeks postpartum, and for 15 days at 3, 6, 9, and 12 months postpartum. ]

Central Contacts

Locations (3)

FacilityCityStateZIPSite coordinators
Sansum Diabetes Research InstituteSanta BarbaraCalifornia93105
Alex AlChwikani, Recruitment Specialist
[email protected]
805-682-7640
Kristin Castorino, DO (PRINCIPAL_INVESTIGATOR)
Oregon Health & Science UniversityPortlandOregon97239
Christian Huertas Pagan
[email protected]
503-418-1231
Amy M Valent, DO, MCR (PRINCIPAL_INVESTIGATOR)
University of PennsylvaniaPhiladelphiaPennsylvania19104
Elizabeth Norton
[email protected]
267-438-2709
Celeste Durnwald, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Santa Barbara, CA

By research site
Sansum Diabetes Research Institute· Santa Barbara, CAOregon Health & Science University· Portland, ORUniversity of Pennsylvania· Philadelphia, PA

Related Studies